Atezolizumab in combination with bevacizumab b
220 Hypoxia-inducible factor-3 (HIF3A) belongs to the hypoxia-inducible factors family (HIFs) that play important roles in the pathogenesis of obesity-induced IR, adipose tissue-inflammation and the etiology of obesity related disease
Composition: Aqua, Butylene Glycol, Glycerin, Japanese Koji Rice Ferment Filtrate, Caprylyl/Capryl Glucoside, Polyglyceryl-10 Isostearate, Sodium Dilauramidoglutamide Lysine, Silica, Sodium Acrylates Crosspolymer-2, Niacinamide, Glycolic Acid, Glutathione, Azadirachta Indica Leaf Extract, Glycyrrhiza Glabra Root Extract, Allantoin, Hydrolyzed Royal Jelly Protein, Disodium EDTA, Phenoxyethanol, Ethylhexylglycerin
For example, you might start with injections once a week, which can later be reduced to once a month for maintenance